Table 4.
Strengths | Weaknesses | |
---|---|---|
Raw EEG | •Relatively available and inexpensive •Should not be affected by muscle relaxant •Artifact recognition •Specific patterns (e.g. isoelectricity) have clinical utility and can be appreciated |
•Requires training to interpret •No well-designed studies evaluating its efficacy at reducing awareness |
Common to both raw and processed EEG | •Might provide evidence with EEG features or with a numerical index that awareness is unlikely •Continues to provide useful information about the brain during CPB |
•Does not reflect NMDA antagonism (e.g. ketamine, N2O) •Affected by underlying brain pathology |
Processed EEG | •Reduces risk of awareness compared with standard care •Allows threshold-based alarms to be set •Interpretation under most clinical situations is simple |
•Lag time between current state of EEG and pEEG index •Underlying algorithms may be poorly understood by those using it, hindering interpretation of artifactual readings •Cost |
CPB, cardiopulmonary bypass; NMDA, N-methyl D-aspratate; pEEG, processed EEG